相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of Cancer
Steven P. Langston et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Cancer-associated fibroblasts downregulate type I interferon receptor to stimulate intratumoral stromagenesis
Christina Cho et al.
ONCOGENE (2020)
Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade
Joseph L. Benci et al.
CELL (2019)
An Interferon-Driven Oxysterol-Based Defense against Tumor-Derived Extracellular Vesicles
Angelica Ortiz et al.
CANCER CELL (2019)
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jerome Galon et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors
Kristian M. Hargadon et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment
Marc L. Hyer et al.
NATURE MEDICINE (2018)
SUMO2 and SUMO3 redundantly prevent a noncanonical type I interferon response
John T. Crowl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
SUMO Safeguards Somatic and Pluripotent Cell Identities by Enforcing Distinct Chromatin States
Jack-Christophe Cossec et al.
CELL STEM CELL (2018)
Innate immune signaling and regulation in cancer immunotherapy
Leticia Corrales et al.
CELL RESEARCH (2017)
Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor
Xingyue He et al.
NATURE CHEMICAL BIOLOGY (2017)
Inactivation of Interferon Receptor Promotes the Establishment of Immune Privileged Tumor Microenvironment
Kanstantsin V. Katlinski et al.
CANCER CELL (2017)
SUMO and the robustness of cancer
Jacob-Sebastian Seeler et al.
NATURE REVIEWS CANCER (2017)
Sumoylation coordinates the repression of inflammatory and anti-viral gene-expression programs during innate sensing
Adrien Decque et al.
NATURE IMMUNOLOGY (2016)
The implication of SUMO in intrinsic and innate immunity
Zara Hannoun et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2016)
Protein SUMOylation Is Required for Regulatory T Cell Expansion and Function
Xiao Ding et al.
CELL REPORTS (2016)
Antitumour actions of interferons: implications for cancer therapy
Belinda S. Parker et al.
NATURE REVIEWS CANCER (2016)
A technology platform to assess multiple cancer agents simultaneously within a patient's tumor
Richard A. Klinghoffer et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Characterization of the Loss of SUMO Pathway Function on Cancer Cells and Tumor Proliferation
Xingyue He et al.
PLOS ONE (2015)
STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
Seng-Ryong Woo et al.
IMMUNITY (2014)
Type I Interferon Protects Antiviral CD8+ T Cells from NK Cell Cytotoxicity
Haifeng C. Xu et al.
IMMUNITY (2014)
Type I Interferons Protect T Cells against NK Cell Attack Mediated by the Activating Receptor NCR1
Josh Crouse et al.
IMMUNITY (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
SUMO: A Multifaceted Modifier of Chromatin Structure and Function
Caelin Cubenas-Potts et al.
DEVELOPMENTAL CELL (2013)
Hope and Fear for Interferon: The Receptor-Centric Outlook on the Future of Interferon Therapy
Serge Y. Fuchs
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2013)
Anti-tumorigenic effects of Type 1 interferon are subdued by integrated stress responses
S. Bhattacharya et al.
ONCOGENE (2013)
Timing and Magnitude of Type I Interferon Responses by Distinct Sensors Impact CD8 T Cell Exhaustion and Chronic Viral Infection
Yaming Wang et al.
CELL HOST & MICROBE (2012)
Inflammatory signaling compromises cell responses to interferon alpha
W-C HuangFu et al.
ONCOGENE (2012)
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells
Mercedes B. Fuertes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Type I interferon is selectively required by dendritic cells for immune rejection of tumors
Mark S. Diamond et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Effects of IFN-α as a signal-3 cytokine on human naive and antigen-experienced CD8+ T cells
Sandra Hervas-Stubbs et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation
Daniele Merico et al.
PLOS ONE (2010)
SUMO engages multiple corepressors to regulate chromatin structure and transcription
Jian Ouyang et al.
EPIGENETICS (2009)
Complete but curtailed T-cell response to very low-affinity antigen
Dietmar Zehn et al.
NATURE (2009)
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
Teresa A. Soucy et al.
NATURE (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Concepts in sumoylation: a decade on
Ruth Geiss-Friedlander et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Dendritic cells prime natural killer cells by trans-presenting interleukin 15
Mathias Lucas et al.
IMMUNITY (2007)
Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia
Elisabeth Kamphuis et al.
BLOOD (2006)
Cutting edge: CD8 T cells specific for lymphocytic choriomeningitis virus require type IIFN receptor for clonal expansion
P Aichele et al.
JOURNAL OF IMMUNOLOGY (2006)
Side effects of interferon-α therapy
S Sleijfer et al.
PHARMACY WORLD & SCIENCE (2005)
Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection
GA Kolumam et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Type I interferons and the innate immune response - more than just antiviral cytokines
PL Smith et al.
MOLECULAR IMMUNOLOGY (2005)
Cutting edge: Type IIFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation
JM Curtsinger et al.
JOURNAL OF IMMUNOLOGY (2005)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
Distinct requirements for IFNs and STAT1 in NK cell function
CK Lee et al.
JOURNAL OF IMMUNOLOGY (2000)
Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
DF Stojdl et al.
NATURE MEDICINE (2000)
IFN-α-expressing tumor cells enhance generation and promote survival of tumor-specific CTLs
K Hiroishi et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
